JPH01144977A - 新規組換えプラスミドpTPGIF2 - Google Patents
新規組換えプラスミドpTPGIF2Info
- Publication number
- JPH01144977A JPH01144977A JP30215487A JP30215487A JPH01144977A JP H01144977 A JPH01144977 A JP H01144977A JP 30215487 A JP30215487 A JP 30215487A JP 30215487 A JP30215487 A JP 30215487A JP H01144977 A JPH01144977 A JP H01144977A
- Authority
- JP
- Japan
- Prior art keywords
- ptpgif2
- coli
- gif
- dhfr
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP30215487A JPH01144977A (ja) | 1987-11-30 | 1987-11-30 | 新規組換えプラスミドpTPGIF2 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP30215487A JPH01144977A (ja) | 1987-11-30 | 1987-11-30 | 新規組換えプラスミドpTPGIF2 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH01144977A true JPH01144977A (ja) | 1989-06-07 |
| JPH0371112B2 JPH0371112B2 (2) | 1991-11-12 |
Family
ID=17905561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP30215487A Granted JPH01144977A (ja) | 1987-11-30 | 1987-11-30 | 新規組換えプラスミドpTPGIF2 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH01144977A (2) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1645631B1 (en) * | 1998-05-01 | 2007-10-24 | Novartis Vaccines and Diagnostics, Inc. | Neisseria antigens and compositions |
| US8563007B1 (en) | 2001-10-11 | 2013-10-22 | Wyeth Holdings Corporation | Immunogenic compositions for the prevention and treatment of meningococcal disease |
| US8574597B2 (en) | 2006-12-22 | 2013-11-05 | Wyeth Llc | Immunogenic compositions for the prevention and treatment of meningococcal disease |
| US10183070B2 (en) | 2017-01-31 | 2019-01-22 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| US10196429B2 (en) | 2012-03-09 | 2019-02-05 | Pfizer Inc. | Neisseria meningitidis composition and methods thereof |
| US10512681B2 (en) | 2010-09-10 | 2019-12-24 | Wyeth Llc | Non-lipidated variants of Neisseria meningitidis ORF2086 antigens |
| US10888611B2 (en) | 2015-02-19 | 2021-01-12 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| US10899802B2 (en) | 2013-09-08 | 2021-01-26 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
-
1987
- 1987-11-30 JP JP30215487A patent/JPH01144977A/ja active Granted
Cited By (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9249198B2 (en) | 1998-05-01 | 2016-02-02 | Glaxosmithkline Biologicals Sa | Neisseria meningitidis antigens and compositions |
| US9139621B2 (en) | 1998-05-01 | 2015-09-22 | Glaxosmithkline Biologicals Sa | Neisseria meningitidis antigens and compositions |
| US7988979B2 (en) | 1998-05-01 | 2011-08-02 | J. Craig Venter Institute, Inc. | Neisseria meningitidis antigens and compositions |
| US8524251B2 (en) | 1998-05-01 | 2013-09-03 | J. Craig Venter Institute, Inc. | Neisseria meningitidis antigens and compositions |
| EP1645631B1 (en) * | 1998-05-01 | 2007-10-24 | Novartis Vaccines and Diagnostics, Inc. | Neisseria antigens and compositions |
| US9249196B2 (en) | 1998-05-01 | 2016-02-02 | Glaxosmithkline Biologicals Sa | Neisseria meningitidis antigens and compositions |
| US7576176B1 (en) | 1998-05-01 | 2009-08-18 | Novartis Vaccines And Diagnostics, Inc. | Neisseria meningitidis antigens and compositions |
| US9266929B2 (en) | 1998-05-01 | 2016-02-23 | Glaxosmithkline Biologicals Sa | Neisseria meningitidis antigens and compositions |
| US8563006B2 (en) | 2001-10-11 | 2013-10-22 | Wyeth Holdings Corporation | Immunogenic compositions for the prevention and treatment of meningococcal disease |
| US11116829B2 (en) | 2001-10-11 | 2021-09-14 | Wyeth Holdings Llc | Immunogenic compositions for the prevention and treatment of meningococcal disease |
| US8563007B1 (en) | 2001-10-11 | 2013-10-22 | Wyeth Holdings Corporation | Immunogenic compositions for the prevention and treatment of meningococcal disease |
| US10300122B2 (en) | 2001-10-11 | 2019-05-28 | Wyeth Holdings Llc | Immunogenic compositions for the prevention and treatment of meningococcal disease |
| US8574597B2 (en) | 2006-12-22 | 2013-11-05 | Wyeth Llc | Immunogenic compositions for the prevention and treatment of meningococcal disease |
| US11077180B2 (en) | 2010-09-10 | 2021-08-03 | Wyeth Llc | Non-lipidated variants of Neisseria meningitidis ORF2086 antigens |
| US10512681B2 (en) | 2010-09-10 | 2019-12-24 | Wyeth Llc | Non-lipidated variants of Neisseria meningitidis ORF2086 antigens |
| US10196429B2 (en) | 2012-03-09 | 2019-02-05 | Pfizer Inc. | Neisseria meningitidis composition and methods thereof |
| US10550159B2 (en) | 2012-03-09 | 2020-02-04 | Pfizer Inc. | Neisseria meningitidis composition and methods thereof |
| US10829521B2 (en) | 2012-03-09 | 2020-11-10 | Pfizer Inc. | Neisseria meningitidis composition and methods thereof |
| US11472850B2 (en) | 2012-03-09 | 2022-10-18 | Pfizer Inc. | Neisseria meningitidis composition and methods thereof |
| US10899802B2 (en) | 2013-09-08 | 2021-01-26 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| US11680087B2 (en) | 2013-09-08 | 2023-06-20 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| US10888611B2 (en) | 2015-02-19 | 2021-01-12 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| US10813989B2 (en) | 2017-01-31 | 2020-10-27 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| US10543267B2 (en) | 2017-01-31 | 2020-01-28 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| US10183070B2 (en) | 2017-01-31 | 2019-01-22 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| US11730800B2 (en) | 2017-01-31 | 2023-08-22 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0371112B2 (2) | 1991-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS60501391A (ja) | ポリペプチドおよび蛋白質生成物、ならびにその製造方法および使用 | |
| JP2787585B2 (ja) | ヒトegfの製造法 | |
| JPH01144977A (ja) | 新規組換えプラスミドpTPGIF2 | |
| JPS63245680A (ja) | 新規組換えプラスミドpG1F1 | |
| JPH1175876A (ja) | 新規な微生物トランスグルタミナーゼの製造法 | |
| CN112824527B (zh) | 人工设计的赖氨酰内切酶及编码序列和发酵方法 | |
| JP2023528996A (ja) | インスリンアスパルト誘導体およびその製造方法と使用 | |
| EP0975742A1 (en) | Aminopeptidase derived from bacillus licheniformis and process for preparation of natural type proteins | |
| JPH0349559B2 (2) | ||
| CN114990097B (zh) | L-天冬氨酸-α-脱羧酶突变体及其应用 | |
| MXPA06006747A (es) | Procesamiento de peptidos y proteinas. | |
| KR100477062B1 (ko) | 바실러스 리케니포미스 유래의 신규한 아미노펩티다아제, 이를 코딩하는 유전자, 이 유전자를 포함하는 발현벡터, 이 발현벡터로 형질전환된 형질전환체 및 이를 이용하는 천연형 단백질의 제조방법 | |
| JPH04117284A (ja) | ジヒドロ葉酸還元酵素―抗アレルギー性ペンタペプチド融合タンパク質 | |
| JPH0371113B2 (2) | ||
| KR970009082B1 (ko) | 인간 알파 아트리알 나트리 우레틱 인자(human α-arterial natriuretic factor; α-hANF)의 미생물학적 제조방법 | |
| JPH0355112B2 (2) | ||
| JPH0355111B2 (2) | ||
| JPS6387981A (ja) | 新規組換えプラスミドpBSFOLEK1およびそれを含有する菌株 | |
| JPH01252286A (ja) | 新規組換えプラスミド、ジヒドロ葉酸還元酵素―ブラジキニン融合タンパク質及びそれらを用いたブラジキニンの製造方法 | |
| JPH02142476A (ja) | 新規組換えプラスミドpGRFM44−6 | |
| JPH0355108B2 (2) | ||
| JPH0355109B2 (2) | ||
| JPH02142481A (ja) | 新規組換えプラスミド、それを含む大腸菌、それを用いて得られるジヒドロ葉酸還元酵素及びその分離精製方法 | |
| JPH0354556B2 (2) | ||
| JPH0355110B2 (2) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |